Pharmacokinetic aspects of theophylline in premature newborns.

To characterize further the pharmacokinetics of theophylline in premature infants, its concentraion in blood was measured by high-pressure liquid chromatography after intravenous infusion given to six apneic premature newborns three to 15 days of age. Theophylline's apparent volume of distribution was 0.690 +/- 0.095 liters per kilogram (mean +/- S.E.), a value similar to that of children, but the half-life (30.2 +/- 6.5 hours) was nine times longer. Blood clearance rate (17.6 +/- 2.3 ml per kilogram per hour) was lower than plasma clearance rate (100 ml per kilogram per hour) of young children. At a total plasma concentration of 17 mg per liter, 56.4 +/- 3.8 and 36.4 +/- 3.8 per cent of the theophylline was bound to adult or full-term cord plasma proteins, respectively. Bilirubin and theophylline did not compete for plasma protein. Calculations suggest that a loading doses of 5.5 mg per kilogram and a maintenance dose rate of 1.1 mg per kilogram per eight hours would achieve and maintain a mean blood concentration of 8 mg per liter (about 10 mg per liter in plasma).

[1]  H. Cornish,et al.  A study of the metabolism of theobromine, theophylline, and caffeine in man. , 1957, The Journal of biological chemistry.

[2]  J. Kuzemko,et al.  Apnoeic attacks in the newborn treated with aminophylline. , 1973, Archives of disease in childhood.

[3]  H. Nagasawa,et al.  Relationship of urinary metabolites of theophylline to serum theophylline levels , 1976, Clinical pharmacology and therapeutics.

[4]  J. Kapitulnik,et al.  Bilirubin binding affinity of serum: comparison of qualitative and quantitative sephadex gel filtration methods. , 1973, Clinical chemistry.

[5]  J. Kapitulnik,et al.  Increase in bilirubin-binding affinity of serum with age of infant. , 1975, The Journal of pediatrics.

[6]  R. Ogilvie,et al.  Pharmacokinetics of intravenous theophylline , 1973, Clinical pharmacology and therapeutics.

[7]  James M. Adams,et al.  Serum Digoxin Levels in Premature-Infants , 1976 .

[8]  J. Aranda,et al.  Hepatic microsomal drug oxidation and electron transport in newborn infants. , 1974, The Journal of pediatrics.

[9]  B. Brodie,et al.  Metabolism of theophylline (1,3-dimethylxanthine) in man. , 1952, The Journal of biological chemistry.

[10]  R. Ogilvie,et al.  Plasma theophylline concentrations measured by high-pressure liquid chromatography. , 1975, Clinical chemistry.

[11]  G. Levy,et al.  Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium , 1975, Clinical pharmacology and therapeutics.

[12]  R. Ogilvie,et al.  Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. , 1976, The Journal of pediatrics.

[13]  R. Uauy,et al.  Treatment of severe apnea in prematures with orally administered theophylline. , 1975, Pediatrics.

[14]  Lucey Jf.  The xanthine treatment of apnea of prematurity. , 1975 .

[15]  R. Ogilvie,et al.  Rational intravenous doses of theophylline. , 1973, The New England journal of medicine.

[16]  P. Loughnan,et al.  Developmental aspects of the hepatic cytochrome P450 monooxygenase system. , 1976, Annual review of pharmacology and toxicology.

[17]  M. C. Rogers,et al.  Prevention of apnea and bradycardia in low-birthweight infants. , 1975, Pediatrics.